|
Market Cap (10-Jun) $4,256,112 (0th) |
Close (30-Jun) $0.069 |
Volume (30-Jun) 53,435 |
Shortsold (24-Oct) 1,681 (0.00%) (629th) |
|
52w High $0.024 |
52w Low $0.024 |
P/E - |
EPS -0.06 |
BOD released this announcement to the ASX on 4 April 2023, 8:52. The announcement is not marked as price sensitive, and is 2 page(s) in length and 231.49kb in size.
You can view all announcements from BOD and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOD was 0.006% short sold according to ASIC data. It was ranked the 606th most shorted stock on the ASX. It remains ranked 629th as of the latest reported data (24 October 2023).
| Other Recent Announcements from BOD | |
|---|---|
| Bod announces progress in Aqua Phase PK Studies | 30 June 2023, 9:50 |
| BOD and Malaysian Antah Group sign Letter of Intent | 21 June 2023, 9:46 |
| Updates regarding Aqua Phase Delivery Technology | 23 May 2023, 9:43 |
| Bod completes recruitment of Phase IIb clinical trial | 4 April 2023, 8:52 |
| Aqua Phase PK Study submitted for ethics approval | 28 March 2023, 8:34 |
| BOD reaches milestone in Schedule 3 CBD clinical trial | 13 March 2023, 8:54 |
| Change of Director's Interest Notice - David Baker | 10 March 2023, 9:21 |
You must be logged in to post a reply.
